Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) EBT Margin (2016 - 2025)

Historic EBT Margin for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to 33.59%.

  • Ekso Bionics Holdings' EBT Margin rose 322300.0% to 33.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 76.35%, marking a year-over-year decrease of 87400.0%. This contributed to the annual value of 59.85% for FY2024, which is 244700.0% up from last year.
  • Ekso Bionics Holdings' EBT Margin amounted to 33.59% in Q3 2025, which was up 322300.0% from 196.4% recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year EBT Margin high stood at 33.59% for Q3 2025, and its period low was 196.4% during Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' median EBT Margin value was 97.87% (recorded in 2022), while the average stood at 102.47%.
  • In the last 5 years, Ekso Bionics Holdings' EBT Margin skyrocketed by 1635200bps in 2021 and then tumbled by -1477400bps in 2025.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' EBT Margin stood at 112.56% in 2021, then dropped by -13bps to 126.78% in 2022, then skyrocketed by 43bps to 72.52% in 2023, then soared by 38bps to 44.97% in 2024, then grew by 25bps to 33.59% in 2025.
  • Its EBT Margin was 33.59% in Q3 2025, compared to 196.4% in Q2 2025 and 104.06% in Q1 2025.